Medirom Healthcare Technologies (MRM) Common Equity (2019 - 2024)
Medirom Healthcare Technologies has reported Common Equity over the past 6 years, most recently at $6.1 million for Q4 2024.
- Quarterly results put Common Equity at $6.1 million for Q4 2024, up 330.3% from a year ago — trailing twelve months through Dec 2024 was $6.1 million (up 330.3% YoY), and the annual figure for FY2024 was $6.1 million, up 330.3%.
- Common Equity for Q4 2024 was $6.1 million at Medirom Healthcare Technologies, up from $1.4 million in the prior quarter.
- Over the last five years, Common Equity for MRM hit a ceiling of $6.1 million in Q4 2024 and a floor of -$1.8 million in Q4 2021.
- Median Common Equity over the past 5 years was $1.4 million (2023), compared with a mean of $2.0 million.
- Biggest five-year swings in Common Equity: plummeted 138.99% in 2021 and later skyrocketed 439.44% in 2023.
- Medirom Healthcare Technologies' Common Equity stood at $4.7 million in 2020, then plummeted by 138.99% to -$1.8 million in 2021, then soared by 77.07% to -$420296.4 in 2022, then skyrocketed by 439.44% to $1.4 million in 2023, then soared by 330.3% to $6.1 million in 2024.
- The last three reported values for Common Equity were $6.1 million (Q4 2024), $1.4 million (Q4 2023), and -$420296.4 (Q4 2022) per Business Quant data.